MedTrace Logo

Sleep Apnea in Heart Failure With Preserved Ejection Fraction

NCT05008432 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2024-08-28

No results posted yet for this study

Summary

This is a prospective interventional study to better understand i) the prevalence of Obstructive Sleep Apnea (OSA) in Heart Failure with preserved Ejection Fraction (HFpEF), ii) its hemodynamic correlates, and iii) the impact of intervention with Continuous Positive Airway Pressure (CPAP) on quality of life.

Conditions

Interventions

DIAGNOSTIC_TEST

Home sleep apnea testing

Participants will be monitored with a WatchPAT device for home based diagnosis of OSA (for patients hospitalized with HFpEF, the sleep test may be performed in the hospital or at home).

Sponsors & Collaborators

  • Itamar-Medical, Israel

    collaborator INDUSTRY

  • Sleep Number Corporation

    collaborator UNKNOWN

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Yogesh Reddy, M.B.B.S. · Mayo Clinic

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-07
Primary Completion
2024-07-24
Completion
2024-07-24

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05008432 on ClinicalTrials.gov